ArticleJournal of traditional Chinese medicine = Chung i tsa chih ying wen pan2025
Pharmacological effect and possible mechanism of Mudan Huaban recipe on melasma in mice induced by ultraviolet B and progesterone.
Article in Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveTo analyze the chemical components of Mudan Huaban recipe (, MHR) and evaluate its efficacy and possible mechanism in melasma mice.
methodsThe chemical compositions of MHR were determined by the ultra-high performance liquid chromatography coupled with quadrupole-exactive mass spectrometry method. Female C57BL/6 mice were exposed to ultraviolet B and progesterone for 21 d to induce melasma, and Fontana-Masson staining was used to assess the effects of MHR on melasma. Luteinizing hormone (LH), estradiol, and follicle-stimulating hormone levels were detected by enzyme-linked immunosorbent assay. The superoxide dismutase (SOD) activity and malonic dialdehyde content were detected by chemiluminescence. Tyrosinase and related proteins expressions were detected by Western blots and immunohistochemistry.
resultsA total of 43 chemical components were identified in MHR, MHR significantly decreased the melanin particles of melasma mice. MHR treatment significantly reversed the high contents of LH and low activity of SOD in models. MHR significantly reduced the higher levels of tyrosinase, tyrosinase-related proteins-1 (TRP-1), TRP-2, microphthalmia-associated transcription factor and phosphorylation of cyclic adenosine monophosphate response element-binding protein (p-CREB)/CREB in the skin of melasma mice.
conclusionsMHR protects against melasma
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.